81
Participants
Start Date
May 4, 2017
Primary Completion Date
January 30, 2020
Study Completion Date
January 30, 2020
MP-101
Capsules
Placebo
Capsules
Richmond Behavioral Associates, Staten Island
Clarity Clinical Research, East Syracuse
CNS, Orlando
Galiz Research, Hialeah
Galiz Research, Miami Springs
Marcus Neuroscience Institute, Boca Raton
University of South Florida, Tampa
Meridien Research Inc, St. Petersburg
Parkinson's Disease Treatment Center of SW Florida, Port Charlotte
Meridien Research, Brooksville
Neurology Diagnostics Inc, Dayton
College Park Family Care Neuro, Overland Park
J. Gary Booker, MD, Clinical Trials, Shreveport
Dignity Health (St. Joseph Hospital and Medical Center), Phoenix
Neuro-Therapeutics Inc, Pasadena
Associated Neurologists of Southern CT, Fairfield
Alzheimer's Research Corporation, Paterson
SKDS Research Inc., Newmarket
Montreal Neurological Institute, Montreal
Centre de recherche sur le vieillissement du CIUSSS de l'Estrie - CHUS, Sherbrooke
Lead Sponsor
Mediti Pharma Inc.
OTHER